Clinical Study

Risk And Protective Factors For Sga-Induced Metabolic Syndrome In Bipolar Youth

Posted Date: May 24, 2017

  • Investigator: Robert Mcnamara
  • Co-Investigator: Sireesha Pothukuchi
  • Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology, Bipolar Disorder
  • Type of Study: Drug

The first purpose of this study is to identify risk factors associated with developing cardiometabolic symptoms and weight gain after taking Quetiapine. Cardiometabolic risk refers to your chances of developing diabetes, elevated blood lipids, and h

Criteria:

Your Child Is Being Asked To Take Part In This Research Study Because He/She Is 10 To 17 Years Of Age (Inclusive) And Has Been Diagnosed With Bipolar Disorder, Type I, Manic Or Mixed Episode And Is Taking Or Is Not Taking Quetiapine.

Keywords:

Quetiapine, Adolescent, Bipolar, Seroquel, Omega 3

For More Information:

Lauren Miller
513-558-4112
milleln@ucmail.uc.edu

  • Search Clinical Studies

  • Research in the News

    Ride Cincinnati Gives $200,000 in Grants for Breast Cancer Research

    Marlene Harris-Ride Cincinnati has continued its support of UC Cancer Institutescientists with the annual award of five grants to continue promising breastcancer research.